The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immunome Inc shares valued at $1,162,500 were purchased by SIEGALL CLAY B on Jan 31 ’25. At $7.75 per share, SIEGALL CLAY B acquired 150,000 shares. The insider’s holdings grew to 669,636 shares worth approximately $7.92 million following the completion of this transaction.
Also, SIEGALL CLAY B purchased 66,057 shares, netting a total of over 630,263 in proceeds. Following the buying of shares at $9.54 each, the insider now holds 485,693 shares.
Before that, SIEGALL CLAY B had added 33,943 shares to its account. In a trade valued at $331,918, the President and CEO bought Immunome Inc shares for $9.78 each. Upon closing the transaction, the insider’s holdings increased to 33,943 shares, worth approximately $6.15 million.
As published in their initiating research note from Stephens on November 08, 2024, Immunome Inc [IMNM] has been an Overweight and the price target has been revised to $30. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in late May. As of April 30, 2024, JP Morgan has initiated its “an Overweight” rating for IMNM. Earlier on April 15, 2024, Guggenheim initiated its rating. Their recommendation was “a Buy” for IMNM stock.
Analyzing IMNM Stock Performance
During the last five days, there has been a surge of approximately 26.52%. Over the course of the year, Immunome Inc shares have jumped approximately 11.39%. Shares of the company reached a 52-week high of $12.22 on 02/05/25 and a 52-week low of $9.06 on 01/29/25. A 50-day SMA is recorded $11.30, while a 200-day SMA reached $13.13. Nevertheless, trading volume fell to 1.0 million shares from 1.63 million shares the previous day.
Support And Resistance Levels for Immunome Inc (IMNM)
According to the 24-hour chart, there is a support level at 11.21, which, if violated, would cause prices to drop to 10.60. In the upper region, resistance lies at 12.33. The next price resistance is at 12.84. RSI (Relative Strength Index) is 60.31 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.83, which suggests the price will decrease in the coming days. Percent R is at 12.34%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
